Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.34 |
| ▸ | FYN | P06241 | 2/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31150378 | 1.00 | CYP1A2 (0.34) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL13080593 | 0.80 | CYP1A2 (0.53) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL2597530 | 0.80 | ALDH1A1 (0.39) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL20551910 | 0.76 | MAPT (0.34) | CA2MAPT | |
| SCHEMBL633807 | 0.74 | CYP1A2 (0.47) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL30203231 | 0.74 | CYP1A2 (0.47) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL29628999 | 0.74 | HSD17B10 (0.47) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL28759609 | 0.74 | HSD17B10 (0.47) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL1816278 | 0.73 | CYP1A2 (0.65) | CYP1A2FYNACHEAHRERBB2 | |
| SCHEMBL1753908 | 0.73 | ERBB2 (0.34) | CYP1A2FYNACHEAHRERBB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2016036-B1 | FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KK (JP) | 2014-06-04 | — | — | EP | disclosed |
| US-8283053-B2 | Fluoranthene derivative and organic light emitting device having the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-09 | — | — | US | disclosed |
| US-8283053-B2 | Fluoranthene derivative and organic light emitting device having the same | CANON KABUSHIKI KAISHA (JP) | 2012-10-09 | — | — | US | disclosed |
| US-7981525-B2 | Naphthalene compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2011-07-19 | — | — | US | disclosed |
| US-7981525-B2 | Naphthalene compound and organic light-emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2011-07-19 | — | — | US | disclosed |
| US-20090102371-A1 | FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20090102371-A1 | FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2008-09-18 | — | — | US | disclosed |
| WO-2007126112-A1 | FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2007-11-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080224603-A1 | NAPHTHALENE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING THE COMPOUND | AHR, CRY1, NR2E3 | CYP1A2 81/4885FYN 4061/4885ACHE 1305/4885 |
| US-20090102371-A1 | FLUORANTHENE DERIVATIVE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | AFF2, LEF1, AFF4 | CYP1A2 28/4885FYN 1369/4885ACHE 636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.